首站-论文投稿智能助手
典型文献
Inducing immunogenic cell death in immuno-oncological therapies
文献摘要:
Immunotherapy has revolutionized cancer treatment and substantially improved patient outcomes with respect to multiple types of tumors.However,most patients cannot benefit from such therapies,mainly due to the intrinsic low immunogenicity of cancer cells(CCs)that allows them to escape recognition by immune cells of the body.Immunogenic cell death(ICD),which is a form of regulated cell death,engages in a complex dialogue between dying CCs and immune cells in the tumor microenvironment(TME),ultimately evoking the damage-associated molecular pattern(DAMP)signals to activate tumor-specific immunity.The ICD inducers mediate the death of CCs and improve both antigenicity and adjuvanticity.At the same time,they reprogram TME with a"cold-warm-hot"immune status,ultimately amplifying and sustaining dendritic cell-and T cell-dependent innate sensing as well as the antitumor immune responses.In this review,we discuss how to stimulate ICD based upon the biological properties of CCs that have evolved under diverse stress conditions.Additionally,we highlight how this dynamic interaction contributes to priming tumor immunogenicity,thereby boosting anticancer immune responses.We believe that a deep understanding of these ICD processes will provide a framework for evaluating its vital role in cancer immunotherapy.
文献关键词:
作者姓名:
Dongdong Ti;Xin Yan;Jianshu Wei;Zhiqiang Wu;Yao Wang;Weidong Han
作者机构:
Department of Bio-therapeutic,the First Medical Center,Chinese PLA General Hospital,Beijing 100853,China
引用格式:
[1]Dongdong Ti;Xin Yan;Jianshu Wei;Zhiqiang Wu;Yao Wang;Weidong Han-.Inducing immunogenic cell death in immuno-oncological therapies)[J].中国癌症研究(英文版),2022(01):1-10
A类:
adjuvanticity
B类:
Inducing,death,oncological,therapies,Immunotherapy,has,revolutionized,treatment,substantially,improved,outcomes,respect,multiple,types,tumors,However,most,patients,cannot,benefit,from,such,mainly,due,intrinsic,immunogenicity,cells,CCs,that,allows,them,escape,recognition,immune,body,Immunogenic,ICD,which,form,regulated,engages,complex,dialogue,between,dying,microenvironment,TME,ultimately,evoking,damage,associated,molecular,pattern,DAMP,signals,activate,specific,immunity,inducers,mediate,both,antigenicity,At,same,they,reprogram,cold,warm,hot,status,amplifying,sustaining,dendritic,dependent,innate,sensing,well,antitumor,responses,this,review,discuss,how,stimulate,upon,biological,properties,have,evolved,diverse,stress,conditions,Additionally,highlight,dynamic,interaction,contributes,priming,thereby,boosting,anticancer,We,believe,deep,understanding,these,processes,will,provide,framework,evaluating,its,vital,role,immunotherapy
AB值:
0.661286
相似文献
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
Xianbin Ma;Shaochen Yang;Tian Zhang;Shuo Wang;Qichao Yang;Yao Xiao;Xiaoxiao Shi;Peng Xue;Yuejun Kang;Gang Liu;Zhi-Jun Sun;Zhigang Xu-Key Laboratory of Luminescence Analysis and Molecular Sensing(Southwest University),Ministry of Education,School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices,Southwest University,Chongqing 400715,China;The State Key Laboratory Breeding Base of Basic Science of Stomatology(Hubei-MOST) & Key Laboratory of Oral Biomedicine,Ministry of Education,School and Hospital of Stomatology,Wuhan University,Wuhan 430079,China;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine,School of Public Health,Xiamen University,Xiamen 361102,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。